Trigeminal nerve and Facial nerve (CN V and CN VII) (CN V and CN VII)

The trigeminal nerve (CN V) and facial nerve (CN VII) are the fifth and seventh cranial nerves, respectively, serving as critical conduits for sensory and motor information in the head and neck [1][2]. The trigeminal nerve is primarily responsible for facial sensation and the motor control of muscles involved in chewing, while the facial nerve governs the muscles of facial expression, taste for the anterior tongue, and autonomic control of tear and salivary glands [1][2]. While these nerves are anatomical structures rather than single molecular targets, they are the site of action for various pharmacological treatments aimed at managing neuropathic pain and muscular dysfunction [3]. For example, sodium channel blockers like carbamazepine are used to treat trigeminal neuralgia by reducing the hyperexcitability of the nerve fibers [3]. Additionally, botulinum toxin is frequently injected near facial nerve branches to treat conditions like hemifacial spasm by inhibiting acetylcholine release at the neuromuscular junction [4]. Therapeutic interventions must be carefully managed to avoid complications such as permanent sensory loss or motor deficits [3][4].

Other names

Cranial nerve V and Cranial nerve VIICN V and CN VIIFifth and seventh cranial nerves

Sodium channel blockade; Inhibition of acetylcholine release; Anti-inflammatory action; Antiviral action.